Cargando…

Associations of Serum Magnesium with Brain Morphology and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities-Neurocognitive Study

Circulating magnesium has been associated with a lower risk of dementia, but the physiologic effects by which magnesium may prevent neurological insults remain unclear. We studied 1466 individuals (mean age 76.2 ± 5.3, 28.8% black, 60.1% female) free of prevalent stroke, with measured serum magnesiu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alam, Aniqa B., Thomas, DaNashia S., Lutsey, Pamela L., Shrestha, Srishti, Alonso, Alvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703422/ https://www.ncbi.nlm.nih.gov/pubmed/34960048 http://dx.doi.org/10.3390/nu13124496

Ejemplares similares

Low Serum Magnesium is Associated with Incident Dementia in the ARIC-NCS Cohort
por: Alam, Aniqa B., et al.
Publicado: (2020)

Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)
por: Schneider, Andrea L.C., et al.
Publicado: (2017)

Circulating Ionized Magnesium: Comparisons with Circulating Total Magnesium and the Response to Magnesium Supplementation in a Randomized Controlled Trial
por: Rooney, Mary R., et al.
Publicado: (2020)

Association Between Thyroid Dysfunction and Incident Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study
por: George, Kristen M., et al.
Publicado: (2019)

Lung Function and Dementia Risk in the Atherosclerosis Risk in Communities (ARIC) Study
por: Shrestha, Srishti, et al.
Publicado: (2021)

Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Full, Kelsie M., et al.
Publicado: (2023)

Association of Abnormal P‐Wave Indices With Dementia and Cognitive Decline Over 25 Years: ARIC‐NCS (The Atherosclerosis Risk in Communities Neurocognitive Study)
por: Gutierrez, Alejandra, et al.
Publicado: (2019)

Effect of Magnesium Supplementation on Circulating Biomarkers of Cardiovascular Disease
por: Alonso, Alvaro, et al.
Publicado: (2020)

Sphingolipids and physical function in the Atherosclerosis Risk in Communities (ARIC) study
por: Li, Danni, et al.
Publicado: (2021)

Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome
por: Nassef, Eman Mostafa, et al.
Publicado: (2022)

A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias
por: Lutsey, Pamela L., et al.
Publicado: (2018)

Atherosclerosis and Cerebrovascular Diseases
por: Blaton, Victor
Publicado: (2004)

Use of SGLT2i and ARNi in patients with atrial fibrillation and heart failure in 2021–2022: an analysis of real-world data
por: Alonso, Alvaro, et al.
Publicado: (2023)

Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
por: Li, Linzi, et al.
Publicado: (2023)

25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
por: Michos, Erin D., et al.
Publicado: (2016)

Association Between a Body Shape Index and Subclinical Carotid Atherosclerosis in Population Free of Cardiovascular and Cerebrovascular Diseases
por: Ma, Xiaotian, et al.
Publicado: (2022)

Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi‐Ethnic Study of Atherosclerosis
por: Polonsky, Tamar S., et al.
Publicado: (2017)

Association of Blood Pressure Control Level With Left Ventricular Morphology and Function and With Subclinical Cerebrovascular Disease
por: Nakanishi, Koki, et al.
Publicado: (2017)

Neurocognitive Functions in Children and Adolescents with Subclinical Hypothyroidism
por: Törel Ergür, Ayça, et al.
Publicado: (2012)

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis
por: Kang, Min Kyoung, et al.
Publicado: (2015)

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
por: Yasar, Hamiyet Yilmaz, et al.
Publicado: (2019)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Carotid Atherosclerosis in Ischemic Cerebrovascular Patients
por: Zhang, Ai Juan, et al.
Publicado: (2009)

Association of physical activity with the incidence of atrial fibrillation in persons > 65 years old: the Atherosclerosis Risk in Communities (ARIC) study
por: Fletcher, Grace, et al.
Publicado: (2022)

Serum gamma-glutamyltransferase is not associated with subclinical atherosclerosis in patients with type 2 diabetes
por: Yoon, Hye Eun, et al.
Publicado: (2016)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
por: Rezaieyazdi, Zahra, et al.
Publicado: (2021)

Exists a role for serum irisin in Egyptian Behcet’s patients with subclinical atherosclerosis?
por: Ismail, Mohamed A., et al.
Publicado: (2022)

Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
por: Knopman, David S., et al.
Publicado: (2016)

Carotid total plaque area as an independent predictor of short-term subclinical polyvascular atherosclerosis progression and major adverse cardiac and cerebrovascular events
por: Genkel, Vadim, et al.
Publicado: (2023)

SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients
por: García-Bermúdez, Mercedes, et al.
Publicado: (2013)

Association of Endothelial and Oxidative Stress with Metabolic Syndrome and Subclinical Atherosclerosis: Multi-Ethnic Study of Atherosclerosis
por: Vaidya, Dhananjay, et al.
Publicado: (2011)

Noninvasive indicators of atherosclerosis in subclinical hypothyroidism
por: Kilic, Ismail Dogu, et al.
Publicado: (2013)

Association of Fat Density With Subclinical Atherosclerosis
por: Alvey, Nicholas J., et al.
Publicado: (2014)

Subclinical atherosclerosis: how and when to treat it?
por: Gatto, Laura, et al.
Publicado: (2020)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan, Jing, et al.
Publicado: (2013)

Associations of urinary isoprostanes with measures of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Wallace, Ryan L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_028ltsb7n17rvg4vpeabgl42gq